Tesamorelin 5mg Vial

Short Description

Tesamorelin (6mg) is a synthetic growth hormone releasing hormone (GHRH) analogue studied in controlled laboratory environments for its interaction with GHRH receptors and downstream endocrine signalling pathways. Supplied as a high-purity lyophilised peptide in a sterile 3ml vial. For research use only.

£28.00

Availability: 15 in stock (can be backordered)

- +
SKU Tesamorelin 5mg Vial Category Tags , ,

Tesamorelin 6mg – 3ml Vial

Product Overview

Tesamorelin is a synthetic analogue of growth hormone releasing hormone (GHRH), structurally modified to enhance stability and receptor interaction in laboratory research systems. It is commonly utilised in controlled in-vitro and pre-clinical models to investigate pituitary signalling and growth hormone axis mechanisms.

In research environments, Tesamorelin is studied for:

  • GHRH receptor (GHRH-R) binding dynamics

  • cAMP-mediated intracellular signalling pathways

  • Pituitary growth hormone axis modelling

  • Endocrine feedback regulation mechanisms

  • Structure–activity relationship research within GHRH analogues

Due to its structural modifications compared to native GHRH, Tesamorelin demonstrates enhanced stability in experimental systems.

Supplied in lyophilised form to preserve peptide integrity and analytical stability prior to reconstitution.

Key Features

  • Synthetic GHRH analogue

  • Studied in pituitary and GH-axis signalling research

  • Investigated in cAMP intracellular pathway models

  • Structurally modified for enhanced stability

  • ≥99% purity (HPLC verified)

  • Lyophilised solid for enhanced stability

  • 6mg per sterile 3ml glass vial

Product Specifications

  • Product Name: Tesamorelin

  • Synonyms: TH9507; GHRH (1–44) Analogue

  • Molecular Class: Synthetic GHRH analogue peptide

  • Amino Acid Sequence (3-Letter Code):
    Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Gly-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH₂

  • Molecular Formula: C221H366N72O67

  • Molecular Weight: ~5135 g/mol

  • CAS Number: 218949-48-5

  • Purity: ≥99% (HPLC)

  • Appearance: White to off-white lyophilised powder

  • Net Content: 6mg

  • Vial Size: 3ml sterile glass vial

  • Storage Form: Lyophilised peptide

  • Intended Use: Laboratory research only

Handling & Storage Guidelines

Unreconstituted (Lyophilised) Storage:
Store at −20°C for long-term preservation. Short-term storage at 2–8°C is acceptable if intended for use within 1–3 months.

Reconstituted Storage:
After reconstitution, store at 2–8°C and use within 3–6 weeks. Stability may vary depending on solvent selection and laboratory handling conditions.

Avoid repeated freeze–thaw cycles. Protect from excessive agitation, heat, and direct light exposure.

Manufacturing & Quality

Tesamorelin is manufactured using precision solid-phase peptide synthesis (SPPS) under GMP-aligned laboratory standards.

Each batch undergoes:

  • High Performance Liquid Chromatography (HPLC) purity verification

  • Mass spectrometry identity confirmation

  • Analytical quality control prior to release

  • Batch traceability and documentation procedures

Products are released only after meeting strict internal quality specifications.

Legal & Safety Notice

This product is supplied strictly for laboratory research purposes only.

Not for human consumption.
Not for therapeutic, diagnostic, or veterinary use.
Not a licensed medicinal product in the United Kingdom.

The purchaser is responsible for ensuring full compliance with all applicable UK laws and regulations relating to research chemicals.

Tesamorelin 5mg VialTesamorelin 5mg Vial
£28.00

Availability: 15 in stock (can be backordered)

- +